Literature DB >> 12435507

A Chlamydia pneumoniae infection model using established human lymphocyte cell lines.

Hiroyuki Yamaguchi1, Shusaku Haranaga, Herman Friedman, Jo A Moor, Karl E Muffly, Yoshimasa Yamamoto.   

Abstract

Since current studies indicate possible infection of human lymphocytes with Chlamydia (Chlamydophila) pneumoniae, establishment of an in vitro C. pneumoniae infection model using lymphocyte cell lines was demonstrated. Human lymphoid cell lines (Molt 4 [T-cell] and P3HR1 [B-cell]) were utilized for this purpose besides human monocyte cell line (THP-1) and human epithelial cell line (HEp-2), as a reference of monocyte/macrophage cells and a positive control for support of C. pneumoniae growth, respectively. Both lymphoid cells (Molt 4 and P3HR1) supported the growth of C. pneumoniae as demonstrated by Chlamydia inclusion formation, detection of increased infective progenies and increased bacterial antigen levels. Similar data were obtained using monocyte THP-1 cells. However, the bacterial growth in these cells was less than that in HEp-2 cells. The electron microscopic study showed typical inclusions with many Chlamydia elementary bodies in lymphoid cells tested, similar to that seen in HEp-2 cells. These results indicate that C. pneumoniae can infect cells with lymphocyte properties and this infection model with lymphoid cell line cells could be valuable to study details of lymphocyte-C. pneumoniae interaction.

Entities:  

Mesh:

Year:  2002        PMID: 12435507     DOI: 10.1111/j.1574-6968.2002.tb11440.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  8 in total

1.  Chlamydia pneumoniae resists antibiotics in lymphocytes.

Authors:  Hiroyuki Yamaguchi; Herman Friedman; Mayumi Yamamoto; Keigo Yasuda; Yoshimasa Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

2.  Cytokine response of lymphocytes persistently infected with Chlamydia pneumoniae.

Authors:  Riho Takano; Hiroyuki Yamaguchi; Shigehiro Sugimoto; Shinichi Nakamura; Herman Friedman; Yoshimasa Yamamoto
Journal:  Curr Microbiol       Date:  2005-03-15       Impact factor: 2.188

3.  Chlamydia trachomatis L2/434/Bu Favors Hypoxia for its Growth in Human Lymphoid Jurkat Cells While Maintaining Production of Proinflammatory Cytokines.

Authors:  Ryoya Tsujikawa; Jeewan Thapa; Torahiko Okubo; Shinji Nakamura; Saicheng Zhang; Yoshikazu Furuta; Hideaki Higashi; Hiroyuki Yamaguchi
Journal:  Curr Microbiol       Date:  2022-07-20       Impact factor: 2.343

4.  Chlamydia pneumoniae growth inhibition in cells by the steroid receptor antagonist RU486 (mifepristone).

Authors:  Hiroyuki Yamaguchi; Shigeru Kamiya; Tomonori Uruma; Takako Osaki; Haruhiko Taguchi; Tomoko Hanawa; Minoru Fukuda; Hayato Kawakami; Hajime Goto; Herman Friedman; Yoshimasa Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

5.  Involvement of nicotinic acetylcholine receptors in controlling Chlamydia pneumoniae growth in epithelial HEp-2 cells.

Authors:  Hiroyuki Yamaguchi; Herman Friedman; Yoshimasa Yamamoto
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

6.  Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections.

Authors:  L G Garcia; S Lemaire; B C Kahl; K Becker; R A Proctor; O Denis; P M Tulkens; F Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2012-05-07       Impact factor: 5.191

7.  A novel inhibitor of Chlamydophila pneumoniae protein kinase D (PknD) inhibits phosphorylation of CdsD and suppresses bacterial replication.

Authors:  Dustin L Johnson; Chris B Stone; David C Bulir; Brian K Coombes; James B Mahony
Journal:  BMC Microbiol       Date:  2009-10-14       Impact factor: 3.605

8.  Detection of Chlamydia in the peripheral blood cells of normal donors using in vitro culture, immunofluorescence microscopy and flow cytometry techniques.

Authors:  Frances Cirino; Wilmore C Webley; Corrie West; Nancy L Croteau; Chester Andrzejewski; Elizabeth S Stuart
Journal:  BMC Infect Dis       Date:  2006-02-10       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.